Unilabs Sverige is the largest private provider of radiology, mammography, laboratory medicine, and pathology services in Sweden. Their services play a crucial role in diagnosis, follow-up, and treatment of patients, serving both public and private healthcare sectors. In radiology, they utilize modern equipment and invest in high human competence to offer high-quality services with competitive prices and short waiting times. In the field of laboratory medicine, they conduct analyses in various clinical areas and make significant investments in information technology, logistics, and the development of new methods. Notably, Unilabs is a leading provider of clinical laboratory tests and medical imaging services across Europe, serving private and public healthcare providers, local authorities, insurance companies, pharmaceutical firms, and the general public. Established in 1987, Unilabs operates laboratories and medical imaging facilities in multiple countries, including the Czech Republic, Denmark, Finland, France, KSA, Norway, Peru, Portugal, Slovakia, Spain, Sweden, Switzerland, the United Arab Emirates, and the United Kingdom. The company's diagnostic network boasts one of the broadest geographic coverage areas among providers of clinical laboratory and medical diagnostic services in Europe. As a player in the healthcare industry, the company's presence and scope indicate significant potential. Currently, there is no publicly available information regarding the last investment or investors involved, which may present an opportunity for venture capitalists interested in the healthcare sector.
There is no investment information
No recent news or press coverage available for Unilabs Sverige.